Insider Transactions in Q3 2021 at Humacyte, Inc. (HUMA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2021
|
William Edward Tente Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,519
+50.0%
|
-
|
|
Aug 26
2021
|
Heather Ledbetter Prichard Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+50.0%
|
-
|
|
Aug 26
2021
|
Jeffrey Harold Lawson Chief Surgical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,877
+50.0%
|
-
|
|
Aug 26
2021
|
Max N. Wallace Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,986
+50.0%
|
-
|
|
Aug 26
2021
|
Ayabudge LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Ayabudge LLC > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
18,930,004
+50.0%
|
-
|
|
Aug 26
2021
|
Brady W Dougan Director |
BUY
Open market or private purchase
|
Indirect |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Brady W Dougan Director |
BUY
Grant, award, or other acquisition
|
Indirect |
20,078,244
+50.0%
|
-
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Open market or private purchase
|
Indirect |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Grant, award, or other acquisition
|
Indirect |
18,930,004
+50.0%
|
-
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,148,240
+50.0%
|
-
|